Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.
about
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityDevelopment of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven ReviewAdverse drug reactions and drug-drug interactions with over-the-counter NSAIDsNew insights into the use of currently available non-steroidal anti-inflammatory drugsFenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent modelsNonsteroidal Anti-Inflammatory Drugs and the KidneyOptimization and pharmacological validation of a leukocyte migration assay in zebrafish larvae for the rapid in vivo bioactivity analysis of anti-inflammatory secondary metabolites2-hydroxy arachidonic acid: a new non-steroidal anti-inflammatory drugComputational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's DiseaseClinical Pharmacology and Cardiovascular Safety of NaproxenEvidence and consensus recommendations for the pharmacological management of pain in India.Identification of in vitro and in vivo disconnects using transcriptomic dataIntra-renal oxygenation in rat kidneys during water loading: effects of cyclooxygenase (COX) inhibition and nitric oxide (NO) donationOxycodone combinations for pain relief.Potential involvement of P2Y2 receptor in diuresis of postobstructive uropathy in rats.Inhibitory effect of Jeju endemic seaweeds on the production of pro-inflammatory mediators in mouse macrophage cell line RAW 264.7.Why pleiotropic interventions are needed for Alzheimer's disease.Prostaglandin E(2) binding peptide screened by phage displaying: a new therapeutic strategy in rheumatoid arthritisInhibition of adjuvant-induced arthritis by nasal administration of novel synthetic peptides from heat shock protein 65.Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depressionPropyphenazone-based analogues as prodrugs and selective cyclooxygenase-2 inhibitors.Cyclooxygenases and lipoxygenases in cancer.Advances in NSAID development: evolution of diclofenac products using pharmaceutical technologyCarprofen for perioperative analgesia causes early anastomotic leakage in the rat ileum.Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese zucker rat mesenteric arteries.Effect of α-tocopheryl succinate on the molecular damage induced by indomethacin in C6 glioma cellsNaproxen induces type X collagen expression in human bone-marrow-derived mesenchymal stem cells through the upregulation of 5-lipoxygenaseIntravenous non-opioid analgesia for peri- and postoperative pain management: a scientific review of intravenous acetaminophen and ibuprofen.Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)Virtual screening of 2,3-disubstituted-4(3H)-quinazolinones possessing benzenesulfonamide moiety for COX-2 inhibitor.Predictive validity of behavioural animal models for chronic painSynthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolaseAfferent drive elicits ongoing pain in a model of advanced osteoarthritis.Non-steroidal Anti-inflammatory Drugs (NSAIDs) Use in Primary Health Care Centers in A'Seeb, Muscat: A Clinical Audit.Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesisMechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain.Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27Low dose aspirin therapy decreases blood glucose levels but does not prevent type i diabetes-induced bone loss
P2860
Q24615651-E0DFC4B8-E8E9-439F-AA69-B05B2AB9E53EQ26750933-8F1B8DC0-2EB4-42B3-B773-362F4D7E975EQ26800279-CB845CE2-5942-4E70-A035-DAB193CB29F0Q26852330-6D612A7C-0D55-4A8D-9F50-6E50DE5D62ECQ27332452-A6C8CF81-8F56-4F27-817E-752364F5A77AQ28386844-E3B4676C-4ABD-491B-B86B-91F2BEC56740Q28534106-3E978047-25B7-4D42-AD07-63B8971D0BC6Q28535742-B1C5D8A8-B660-46FA-BE47-789DB46D6184Q28546991-ABB7E7B4-EC5E-4E17-8DA3-F6C0DEEC862EQ28828576-0E458369-156A-4F19-8973-BE7D6C937213Q30360728-4B58633F-CEC8-4604-854F-A1DBB0E267BEQ30844805-D886E7F1-57E7-4F0E-AA38-246CF980442DQ30987816-628E61AD-EB82-49D8-A20B-133993AECF6AQ33647185-4A7B4D49-C423-4159-91B2-313A50B71608Q33713626-A5FB53E4-B1DD-4B97-9905-72C51038DFDAQ33727799-CC685DF6-5A27-4940-8692-5A1C40C130C5Q33834601-811DB709-FA06-4602-A83A-BA667A14460BQ33876128-A3C0444B-6738-4191-A993-CB54F59A602EQ33899147-DBB10ABE-016B-4EBE-A154-6D3E02D543BFQ33970282-554BAFF9-C2C0-4863-A34F-CF2B460F8694Q34090453-19319FEE-186F-4116-8086-A3ED42E8F509Q34162643-44B09483-37EB-4B53-9E14-0FFA407013C1Q34224752-164B2B34-E923-4CAA-9E16-660B9CFB10EDQ34475981-37F557C2-F162-4246-94C6-6AC1CD6A072DQ34523584-B22362BE-EC8C-40AB-ACDE-60AAB623278EQ34691844-604F8AD5-5928-4A9C-A986-6D9BA9DA37AFQ34795572-A69EA116-F4BD-41A5-91D2-A03DE65E435CQ34938495-B368E9D8-CF52-4380-AD9A-EDB9E10C1192Q35054937-FA47E21B-DC44-48A2-B1AE-96474147D6EFQ35124699-81C3A106-49B9-4D69-9D7C-56E0A0702D68Q35556534-1882738C-F4C5-4559-A907-BCF5D3EB076FQ35589944-3257DA9D-BF79-43C8-AF8B-6773750015C3Q35762636-235C4515-950B-4958-9268-B3202BC58A28Q35855535-046DCFB3-A313-4122-AA6C-53FAF7C8153BQ36076845-F8BC3E4E-32F0-4678-976E-F4FE04C3C27EQ36099347-C54EB79B-A3F8-4301-961C-67B29F7A4B38Q36124999-5FBBFF84-F846-40C0-9729-561913AD6116Q36235082-E1D2A74C-4B71-462F-A159-D0B22F3B3476Q36919383-E5FEF7E6-4BBC-449E-8979-DCB616186904Q37005199-DA9E8FE0-D647-4B09-AC2A-1A0FED9C0ADE
P2860
Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Evolution of nonsteroidal anti ...... e (COX) inhibition and beyond.
@ast
Evolution of nonsteroidal anti ...... e (COX) inhibition and beyond.
@en
Evolution of nonsteroidal anti-inflammatory drugs
@nl
type
label
Evolution of nonsteroidal anti ...... e (COX) inhibition and beyond.
@ast
Evolution of nonsteroidal anti ...... e (COX) inhibition and beyond.
@en
Evolution of nonsteroidal anti-inflammatory drugs
@nl
prefLabel
Evolution of nonsteroidal anti ...... e (COX) inhibition and beyond.
@ast
Evolution of nonsteroidal anti ...... e (COX) inhibition and beyond.
@en
Evolution of nonsteroidal anti-inflammatory drugs
@nl
P1476
Evolution of nonsteroidal anti ...... e (COX) inhibition and beyond.
@en
P2093
Edward E Knaus
Praveen Rao
P304
P407
P577
2008-09-20T00:00:00Z